Vaginal misoprostol versus dinoprostone for the management of missed abortion

International Journal of Gynecology and Obstetrics

Volumn 83, Issue 1, 2003, Pages 73-74

  Thwaini Al Inizi, S A ^a   Ezimokhai, M ^b  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Dinoprostone; Misoprostol; Missed abortion

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN E2;

ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; MISSED ABORTION; PATIENT SATISFACTION; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TABLET; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UNITED ARAB EMIRATES; VAGINA BLEEDING;

EID: 0141849027     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(03)00199-1     Document Type: Article

References (2)

1. Wood S.L., Brain P.H. Medical management of missed abortion: a randomized control trial. Obstet Gynecol. 99:(4):2002;563-566.
2. Nielsen S., Hahlin M., Oden A. Using a logistic model to identify women with first trimester spontaneous abortion suitable for expectant management. Br J Obstet Gynaecol. 103:1996;1230-1235.